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A New Wrinkle on Topical Vitamin E 
and Photo-inflammation: Mechanistic 
Studies of a Hydrophilic γ-Tocopherol 
Derivative Compared with 
α-Tocopherol
Raymond L. Konger1,2
The antioxidant function of vitamin E is thought to mediate its photo-protec-
tive effects. Cyclooxygenase-2 (COX-2) is an important mediator of early 
photo-inflammation. Thus, the ability of γ-tocopherol to inhibit COX-2 activity 
independently of its antioxidant function raises important questions regarding 
potential roles that this form of vitamin E plays in photo-protection and skin 
cancer chemoprevention.
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Since Linus Pauling published his 
widely read and publicly debated trea-
tise Vitamin C and the Common Cold 
in 1970, there has been tremendous 
lay interest in the potential protective 
effects of antioxidants in a variety of ail-
ments. This interest did not escape the 
cosmetic industry. Currently, pharmacy 
shelves are well stocked with skin-care 
products, sunblocks, and sun-tanning 
lotions that tout the remarkable anti-
oxidant properties of vitamin E. Given 
that there is good evidence that vita-
min E may have protective functions 
within the epidermis, this widespread 
use cannot be simply trivialized as a 
long-term marketing ploy. However, 
there is no good consensus regarding 
the clinical utility of the various natu-
rally occurring forms of vitamin E, nor 
the widely used thermostabile esteri-
fied forms of vitamin E. This is partly 
because, beyond its antioxidant effect, 
very little is known regarding the cel-
lular mechanisms through which the 
different biologically relevant forms 
of vitamin E work. Yoshida and col-
leagues (2006, this issue) demonstrate 
that a novel water-soluble vitamin E 
derivative, γ-tocopherol-N,N-dimeth-
ylglycinate hydrochloride (γ-TDMG), 
may be superior to the widely used 
α-tocopherol (α-Toc) form of vita-
min E in suppressing UVB-induced 
photo-inflammation. Moreover, they 
demonstrate that γ-TDMG inhibits the 
production of two inflammatory medi-
ators, prostaglandin E2 (PGE2) and nitric 
oxide. Finally, Yoshida et al. provide 
evidence that the ability of γ-TDMG to 
block PGE2 production may be inde-
pendent of its antioxidant properties. 
This has important implications not 
only for epidermal photo-protection 
and chemoprevention, but also for cur-
rent studies examining the chemopre-
ventive effects of vitamin E on other 
epithelial malignancies, particularly 
prostate, colon, and lung cancer.
Historical perspective
Vitamin E was first described in 1922 by 
Herbert M. Evans and Katharine Bishop. 
In their studies, an unknown factor 
that they called vitamin E was found to 
be necessary for fetal development in 
rats. Fetal development was found to 
be aborted in female rats fed a defined 
diet. However, fetal development was 
restored by the addition of plant mate-
rial, the most effective being wheat germ 
oil. Vitamin E was subsequently iso-
lated in 1936 and was given the name 
tocopherol, or “the childbirth-producing 
alcohol” (Greek tokos, childbirth; phere-
in, to bear; ol, an alcohol). In 1938, Paul 
Karrer synthesized vitamin E and dem-
onstrated its function as a lipid-soluble 
antioxidant. By the 1940s and 1950s, 
the antioxidant activity of vitamin E was 
well established, and it was recognized 
as an essential nutrient in 1968. Natural 
plant-derived vitamin E is composed of 
eight different natural derivatives (α-, 
β-, γ-, and δ-tocopherols and the related 
α-, β-, γ-, and δ-tocotrienols). Whereas 
γ-tocopherol (γ-Toc) is the most abun-
dant tocopherol found in the diet, 
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α-Toc represents the most abundant 
vitamin E derivative found in most 
human tissues and sera, with γ-Toc 
being the only other tocopherol found 
in biologically relevant amounts. This 
discrepancy between dietary consump-
tion of α- and γ-Toc and the levels of 
these tocopherols in tissue and blood is 
due to differences in metabolism, trans-
port, and excretion that favor reten-
tion of α-Toc (Jiang et al., 2001). Thus, 
given its higher tissue levels, α-Toc has 
been the primary tocopherol used in 
dietary supplements and in research 
studies over the past 30 to 40 years. 
Various studies during this period indi-
cate that the incidence of a number of 
malignancies, including lung, colon, 
and prostate, exhibits an inverse cor-
relation with blood levels of vitamin E. 
However, with the exception of pros-
tate cancer, more recent randomized 
controlled studies have failed to show 
a correlation between dietary supple-
mentation with α-Toc and reduced can-
cer risk (Ritenbaugh et al., 2003). This 
past focus on α-Toc may have resulted 
in the failure to recognize the potential 
unique contributions of γ-Toc to human 
pathophysiology (reviewed by Jiang 
et al., 2001). First, human and animal 
studies indicate that plasma levels of γ-
Toc exhibit greater inverse correlation 
with the incidence of cardiovascular 
disease and prostate cancer. Second, 
whereas α-Toc exhibits a modest 
increase in the ability to suppress lipid 
peroxidation, γ-Toc is a more effective 
trap for lipophilic electrophiles, such 
as reactive nitrogen oxide species (for 
example, peroxynitrite and nitrogen 
dioxide). Third, oral supplementation 
of α-Toc has been shown to suppress 
tissue γ-Toc levels, whereas oral γ-Toc 
supplementation increases the tissue 
levels of both α-Toc and γ-Toc. Finally, 
γ-Toc and its water-soluble metabolite 
2,7,8-trimethyl-2-(β-carboxyethyl)-6-
hydroxychroman (γ-CEHC) have been 
shown to inhibit the enzymatic activ-
ity of the inducible form of cyclooxy-
genase (COX-2) in macrophages and 
epithelial cells and after carrageenan-
induced inflammation in rats (Jiang et 
al., 2001; Jiang and Ames, 2003). This 
suppression of COX-2 activity was not 
dependent on the antioxidant func-
tion of either γ-Toc or γ-CEHC, and this 
effect was not observed when equiva-
lent concentrations of α-Toc were used. 
Given the important role of COX-2 in 
inflammation and tumorigenesis, this 
suggests that γ-Toc may exhibit supe-
rior anti-inflammatory and chemopre-
ventive properties as compared with 
α-Toc.
Vitamin E as a photo-protectant
The epidermis, acting as the primary 
barrier to fluid loss and environmental 
insult, is constantly exposed to UV light 
and other oxidative stressors. This con-
stant oxidative barrage leaves its mark 
on the epidermis, resulting in photo-
toxicity, immunosuppression, photo-
aging, and cutaneous neoplasia (Fuchs, 
1998). Because of its potent antioxi-
dant and lipophilic properties, vita-
min E is thought to play a key role in 
protecting epidermal cell membranes 
and lipids from oxidative damage. 
Numerous studies have demonstrated 
a role for topical vitamin E in reducing 
both acute and chronic UV-mediated 
skin responses, such as erythema and 
edema, sunburn-cell formation, DNA 
photo-adduct formation, immunosup-
pression, and photo-carcinogenesis 
(Thiele et al., 2005). However, because 
of the inherent instability of α-Toc, both 
topical preparations and oral supple-
ments often use inactive α-Toc esters 
(for example, α-tocopherol acetate). 
This may serve to increase shelf-life, 
but there is considerable debate as to 
whether appreciable bioconversion 
of these inactive esters to the active 
nonesterified form occurs in the skin 
(Fuchs, 1998; Thiele et al., 2005). 
Moreover, there is some evidence that 
the use of these esterified tocopherols 
may actually enhance photo-carcino-
genesis (Gensler et al., 1996).
The role of γ-tocopherol in epidermis
Whereas there is evidence that topi-
cal α-Toc is a potent cutaneous photo-
protectant, there is much less informa-
tion concerning γ-Toc in epidermal biol-
ogy. Thus, it is interesting that in human 
skin, γ-Toc levels exceed those of α-Toc 
(Jiang et al., 2001). This contrasts with 
the higher level of α-Toc found in other 
tissues and in serum and suggests that 
γ-Toc plays an important role in epider-
mal protection from oxidative stress. In 
addition, studies using γ-Toc have been 
limited by its near-complete insolubil-
ity in water and the fact that it is readily 
oxidized by atmospheric oxygen. These 
physico-chemical restraints appear to 
have been remedied by the synthesis 
of the water-soluble γ-Toc derivative 
γ-TDMG (Takata et al., 2002). By adding 
an N,N-dimethylglycine ester group to 
the phenolic functional group of γ-Toc, 
the investigators achieved a hydrophilic 
prodrug that is resistant to oxidation and 
is readily converted to the active γ-Toc 
after systemic administration. This group 
subsequently demonstrated that topical-
ly administered γ-TDMG was absorbed 
and efficiently bioconverted both into 
γ-Toc and, subsequently, into γ-CEHC 
(Yasuoka et al., 2005). Notably, the bio-
conversion was much greater than that 
observed for two commonly used α-Toc 
esters (α-Toc acetate and α-TDMG). In 
this same report, γ-TDMG exhibited sig-
nificantly greater ability to prevent sun-
burn-cell formation, lipid peroxidation, 
and edema and inflammation than the 
two α-Toc esters. However, this study did 
not clarify whether the improved bio-
logical outcome with the use of γ-TDMG 
was simply due to its higher rate of bio-
conversion.
As they report in this issue, this same 
group of investigators expanded on 
the earlier studies by applying doses 
of γ-TDMG and α-Toc acetate (α-TA) 
that result in equivalent levels of active 
γ-Toc and α-Toc within the epidermis 
(Yoshida et al., 2006). They then exam-
ined the effect of both agents on UVB-
induced photo-inflammation. When 
applied 1 hour before UVB irradia-
tion, both α-TA and γ-TDMG showed 
similar abilities to inhibit UVB-induced 
edema and PGE2 production. Notably, 
when applied 1 hour after UVB irradia-
tion, γ-TDMG was still highly effective, 
whereas the α-TA response was consid-
erably suppressed. This is an important 
distinction, as the authors also confirm 
|γ-TDMG … directly inhibits COX-2 activity independently of its ability to scavenge reactive 
oxygen species.
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earlier reports that α-Toc pretreatment 
exhibits a greater capacity to block 
UVB-induced lipid peroxidation. Thus, 
the ability of γ-TDMG, but not α-TA, 
to maintain anti-inflammatory activ-
ity when applied after UVB irradiation 
suggests that this ability is not mediated 
solely by antioxidant activity.
This idea is further supported by sev-
eral additional studies. First, the authors 
show that pretreatment with α-TA was 
more effective in suppressing UVB-
induced COX-2 mRNA and protein 
expression as compared with γ-TDMG 
(Yoshida et al., 2006). This suggests that 
α-TA, via its greater antioxidant prop-
erties, has a greater capacity to reduce 
UVB-mediated COX-2 induction. This is 
not surprising, given that oxidative stress 
has previously been shown to trigger 
COX-2 expression (Zhang et al., 2005). 
In contrast, γ-TDMG pretreatment was 
more effective than α-TA in inhibiting 
UVB-induced COX-2 enzymatic activity. 
This indicates that γ-TDMG, presumably 
acting via γ-Toc and γ-CEHC, directly 
inhibits COX-2 activity independently 
of its ability to scavenge reactive oxygen 
species. These results support the ear-
lier findings of Jiang and colleagues that 
γ-Toc, but not α-Toc, directly inhibits 
COX-2 activity (Jiang et al., 2001; Jiang 
and Ames, 2003). It should be noted 
that these additional studies examin-
ing COX-2 expression and activity only 
addressed γ-TDMG and α-TA pretreat-
ment. Yet γ-TDMG markedly suppressed 
UVB-induced PGE2 production even 
when γ-TDMG was applied 1 hour after 
UVB irradiation. As UVB-induced reac-
tive oxygen species are significantly 
elevated up to 90 minutes after an acute 
exposure (Wang and Kochevar, 2005), 
it would be interesting to determine 
the degree to which this post-treatment 
response is dependent on manipulation 
of COX-2 expression or inhibition of 
COX-2 enzymatic activity.
In addition to COX-2, nitric oxide 
and inducible nitric oxide synthase 
contribute to UVB-induced photo-
inflammation. Moreover, α-TA has been 
previously shown to suppress COX-2 
activity via its ability to block peroxyni-
trite production formed from the reac-
tion of nitric oxide with O2
– radicals 
(Beharka et al., 2002). As γ-Toc has 
been reported to have greater capacity 
to block reactive nitrogen oxide species 
formation, this may help to explain the 
increased capacity of γ-Toc to inhibit 
COX-2 activity. However, this idea is 
not supported by the next experiment 
of Yoshida et al. (2006). In this experi-
ment, they demonstrated that γ-TDMG 
and α-TA were equally effective in 
blocking nitrite production and that 
γ-TDMG was only slightly more effec-
tive in inhibiting inducible nitric oxide 
synthase expression.
In conclusion, the study by Yoshida 
et al. (2006) indicates that γ-TDMG 
is superior to α-TA in blocking UVB-
induced photo-inflammation. In par-
ticular, the effectiveness of γ-TDMG in 
blocking UVB-induced photo-inflam-
mation was maintained when it was 
applied after the UVB dose. This is 
important given the typical patterns 
of sunscreen use, in which sunscreen 
is applied just before or at some point 
after initial sun exposure. These data 
also raise several important questions. 
First, how long after UVB irradiation 
can γ-TDMG provide photo-protec-
tion? Given the ability of γ-TDMG 
to suppress PGE2 levels 1 hour after 
UVB irradiation, additional studies 
are needed to verify whether post-
treatment with γ-TDMG also inhibits 
UVB-induced COX-2 activity, lipid 
peroxidation, reactive nitrogen oxide 
species formation, and inducible nitric 
oxide synthase suppression. In addi-
tion, the mechanism through which 
γ-TDMG suppresses COX-2 expression 
and activity is unclear. Most important-
ly, these findings suggest that γ-TDMG 
may be a superior investigational tool 
for UVB photo-carcinogenesis studies.
CONFLICT OF INTEREST
The author states no conflict of interest.
REFERENCES
Beharka AA, Wu D, Serafini M, Meydani SN 
(2002) Mechanism of vitamin E inhibition of 
cyclooxygenase activity in macrophages from 
old mice: role of peroxynitrite. Free Radic Biol 
Med 32:503–11
Fuchs J (1998) Potentials and limitations of the 
natural antioxidants RRR-alpha-tocopherol, L-
ascorbic acid and beta-carotene in cutaneous 
photoprotection. Free Radic Biol Med 25:848–
73
Gensler HL, Aickin M, Peng YM, Xu M (1996) 
Importance of the form of topical vitamin E 
for prevention of photocarcinogenesis. Nutr 
Cancer 26:183–91
Jiang Q, Ames BN (2003) Gamma-tocopherol, 
but not alpha-tocopherol, decreases 
proinflammatory eicosanoids and 
inflammation damage in rats. FASEB J 17:816–
22
Jiang Q, Christen S, Shigenaga MK, Ames BN 
(2001) γ-Tocopherol, the major form of 
vitamin E in the US diet, deserves more 
attention. Am J Clin Nutr 74:714–22
Ritenbaugh C, Streit K, Helfand M (2003) Routine 
vitamin supplementation to prevent cancer: 
a summary of the evidence from randomized 
controlled trials for the U.S. Preventive 
Services Task Force. Agency for Healthcare 
Research and Quality: Rockville, Maryland, 
USA. Guide to Clinical Preventive Services, 
Third Edition: Periodic Updates, 1–22
Takata J, Hidaka R, Yamasaki A, Hattori A, 
Fukushima T, Tanabe M et al. (2002) Novel 
d-γ-tocopherol derivative and a two-step 
prodrug for S-γ-CEHC. J Lipid Res 43:2196–
204
Thiele JJ, Hsieh SN, Ekanayake-Mudiyanselage S 
(2005) Vitamin E: critical review of its current 
use in cosmetic and clinical dermatology. 
Dermatol Surg 31:805–13; discussion 813
Wang H, Kochevar IE (2005) Involvement of UVB-
induced reactive oxygen species in TGF-beta 
biosynthesis and activation in keratinocytes. 
Free Radic Biol Med 38:890–7
Yasuoka S, Takata J, Karube Y, Katoh E, Tsuzuki, 
Kizu J et al. (2005) Topical application of 
a novel, water-soluble gamma-tocopherol 
derivative prevents UV-induced skin damage 
in mice. Photochem Photobiol 81:908–13
Yoshida E, Watanabe T, Takata J, Yamazaki 
A, Karube Y, Kobayashi S (2006) Topical 
application of a novel, hydrophilic γ-
tocopherol derivative reduces photo-
inflammation in mice skin. J Invest Dermatol 
126:1633–1640
Zhang Q, Southall MD, Mezsick SM, Johnson C, 
Murphy RC, Konger RL et al. (2005) Epidermal 
peroxisome proliferator-activated receptor 
gamma as a target for ultraviolet B radiation. 
J Biol Chem 280:73–9
